![Hypercholestérolémie : la HAS recommande d'utiliser l'outil SCORE en prévention primaire entre 40 et 65 ans | Le Quotidien du Médecin Hypercholestérolémie : la HAS recommande d'utiliser l'outil SCORE en prévention primaire entre 40 et 65 ans | Le Quotidien du Médecin](https://static2.lequotidiendumedecin.fr/cdn/ff/kx4QoBd4Aqn-lZ6jtYBcU1LhJr_x4gSBOw6k34eZr10/1587308108/public/styles/gps_large/public/public/images/846158/35953_IMG_17556_HR.jpg?itok=JPUa0mpR)
Hypercholestérolémie : la HAS recommande d'utiliser l'outil SCORE en prévention primaire entre 40 et 65 ans | Le Quotidien du Médecin
![Montreal-FH-SCORE Predicts Coronary Artery Calcium Score in Patients With Familial Hypercholesterolemia - CJC Open Montreal-FH-SCORE Predicts Coronary Artery Calcium Score in Patients With Familial Hypercholesterolemia - CJC Open](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d76dad02-0cde-45c8-a0f0-a7e91911a21f/gr3_lrg.jpg)
Montreal-FH-SCORE Predicts Coronary Artery Calcium Score in Patients With Familial Hypercholesterolemia - CJC Open
![Montreal-FH-SCORE Predicts Coronary Artery Calcium Score in Patients With Familial Hypercholesterolemia - CJC Open Montreal-FH-SCORE Predicts Coronary Artery Calcium Score in Patients With Familial Hypercholesterolemia - CJC Open](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ee12aaac-f8da-461c-b137-01ebad9d57df/gr1_lrg.jpg)
Montreal-FH-SCORE Predicts Coronary Artery Calcium Score in Patients With Familial Hypercholesterolemia - CJC Open
![C-Reactive Protein and Other Emerging Blood Biomarkers to Optimize Risk Stratification of Vulnerable Patients | Journal of the American College of Cardiology C-Reactive Protein and Other Emerging Blood Biomarkers to Optimize Risk Stratification of Vulnerable Patients | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/d2a34ae8-b419-4a30-994d-1283d9068155/gr1.jpg?download)
C-Reactive Protein and Other Emerging Blood Biomarkers to Optimize Risk Stratification of Vulnerable Patients | Journal of the American College of Cardiology
![Lipoprotein(a): Pathophysiology, measurement, indication and treatment in cardiovascular disease. A consensus statement from the Nouvelle Société Francophone d'Athérosclérose (NSFA) - ScienceDirect Lipoprotein(a): Pathophysiology, measurement, indication and treatment in cardiovascular disease. A consensus statement from the Nouvelle Société Francophone d'Athérosclérose (NSFA) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1875213621001868-fx1.jpg)
Lipoprotein(a): Pathophysiology, measurement, indication and treatment in cardiovascular disease. A consensus statement from the Nouvelle Société Francophone d'Athérosclérose (NSFA) - ScienceDirect
![Assessing the accuracy of a point‐of‐care analyzer for hyperlipidaemia in western Kenya - Park - 2016 - Tropical Medicine & International Health - Wiley Online Library Assessing the accuracy of a point‐of‐care analyzer for hyperlipidaemia in western Kenya - Park - 2016 - Tropical Medicine & International Health - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/bf5b4cd9-aa40-4021-b191-e5ad4b7f6836/tmi.2016.21.issue-3.cover.jpg?trick=1665264532715)
Assessing the accuracy of a point‐of‐care analyzer for hyperlipidaemia in western Kenya - Park - 2016 - Tropical Medicine & International Health - Wiley Online Library
The use of statins in the primary prevention of cardiovascular disease: an online tool for shared-decision making
![Obesity, body fat distribution and incidence of sick leave in the Belgian workforce: the Belstress study | International Journal of Obesity Obesity, body fat distribution and incidence of sick leave in the Belgian workforce: the Belstress study | International Journal of Obesity](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.ijo.0802600/MediaObjects/41366_2004_Article_BF0802600_Fig7_HTML.gif)
Obesity, body fat distribution and incidence of sick leave in the Belgian workforce: the Belstress study | International Journal of Obesity
Les nouveLLes recommandations européennes pour Le traitement des dysLipidémies en prévention cardiovascuLaire
![Relative risk chart, derived from SCORE Conversion of cholesterol... | Download High-Quality Scientific Diagram Relative risk chart, derived from SCORE Conversion of cholesterol... | Download High-Quality Scientific Diagram](https://www.researchgate.net/profile/Monica-Tiberi-2/publication/304574403/figure/fig4/AS:613444923449367@1523268075319/Relative-risk-chart-derived-from-SCORE-Conversion-of-cholesterol-mmol-L-mg-dL-8-14-310.png)